...
首页> 外文期刊>Pharmacological reports: PR >REVIEW - Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung.
【24h】

REVIEW - Mechanisms of platelet-activating factor (PAF)-mediated responses in the lung.

机译:审查-血小板活化因子(PAF)介导的肺部反应机制。

获取原文
           

摘要

Platelet-activating factor (PAF) is a potent lipid mediator that has been implicated in asthma, sepsis, acute lung injury and ischemia/reperfusion injury. Its actions in the lungs include vasoconstriction, bronchoconstriction, and edema formation. Despite the fact that PAF exerts these actions within minutes, they are mediated by other lipid mediators, in particular eicosanoids generated by cyclooxygenase and lipoxygenase enzymes and sphingolipids generated by acid sphingomyelinase.We will discuss the mechanisms of the PAF-induced pressor responses that are triggered by thromboxane A?? and leukotrienes, as well the PAF-induced increase in vascular permeability that is mediated by prostaglandin E?? (PGE??) and ceramide.
机译:血小板活化因子(PAF)是一种有效的脂质介体,与哮喘,败血症,急性肺损伤和局部缺血/再灌注损伤有关。它在肺部的作用包括血管收缩,支气管收缩和水肿形成。尽管PAF会在数分钟内发挥这些作用,但它们是由其他脂质介体介导的,尤其是环氧合酶和脂氧合酶产生的类花生酸以及酸性鞘磷脂酶产生的鞘脂。我们将讨论PAF诱导的升压反应触发的机制由血栓烷A?和白三烯,以及由前列腺素Eβ介导的PAF诱导的血管通透性增加(PGE-)和神经酰胺。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号